Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact)
|顯影劑(影像診斷)-全球市場分析及預測模式(COVID-19對市場造成的影響) Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact)|
|出版日期: 2020年11月30日||內容資訊: 英文||
網羅的企業-BayerAG，GE 醫療保健 LLC，Guerbet SA，Bracco Imaging SpA，Lantheus Medical Imaging，其他
Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.
The model discusses in detail the impact of COVID-19 on Contrast Agents market for the year 2020 and beyond. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computated tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among other modalities. Within CT, non-ionic iodinated agents are preferred over ionic iodinated agents for most CT procedures. Barium-based agents are generally used for imaging the GI tract. MRI contrast agents can be used for a variety of procedures, while ultrasound contrast agents are currently mainly used for echocardiograms.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Contrast Agents and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Bayer AG, GE Healthcare LLC, Guerbet SA, Bracco Imaging SpA, Lantheus Medical Imaging, and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Who should buy this report?
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -